EAU2018 Copenhagen – Stand A26
For the latest results for HIVEC and the use of the COMBAT System, attend this session at the 2018 Genitourinary Cancers Symposium!
Chemohyperthermia with Mitomycin C and COMBAT system in High Risk Non-Muscle Invasive Bladder Cancer patients: Initial experience in a single center
Quality of life (QoL), Non Muscle Invasive Bladder Cancer (NMIBC) and Endovesical Treatments: Instillation matters.
The role of conductive hyperthermia with mitomycin in High Risk Non Muscle Invasive Bladder Cancer that has failed BCG therapy